The organization and financing of dialysis and kidney transplantation services in New Zealand

Int J Health Care Finance Econ. 2007 Dec;7(4):233-52. doi: 10.1007/s10754-007-9023-x.


In New Zealand, patients receive treatment for end-stage renal disease (ESRD) within the tax-funded health system. All hospital and specialist outpatient services are free, while general practitioner consultations and pharmaceuticals prescribed outside of hospitals incur copayments. Total ESRD prevalence is 0.07%, half the U.S. rate, and the prevalence of home-based and self-care dialysis is the highest in the world. Medical staff are not subject to direct financial incentives that could affect treatment choice. Estimated total expenditure per ESRD patient is relatively low. Funding constraints encourage physicians and patients to consider the probable benefit of dialysis for a patient before treatment is prescribed.

MeSH terms

  • Delivery of Health Care / economics
  • Delivery of Health Care / organization & administration*
  • Health Care Costs
  • Health Care Rationing / organization & administration
  • Health Services Research
  • Home Care Services / organization & administration
  • Humans
  • Kidney Failure, Chronic / economics*
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / therapy*
  • Kidney Transplantation / economics*
  • National Health Programs / economics
  • National Health Programs / organization & administration*
  • New Zealand / epidemiology
  • Renal Dialysis / economics*
  • Self Care / economics